These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 37814060)

  • 1. Recent successes in heart failure treatment.
    Lam CSP; Docherty KF; Ho JE; McMurray JJV; Myhre PL; Omland T
    Nat Med; 2023 Oct; 29(10):2424-2437. PubMed ID: 37814060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology.
    Seferović PM; Polovina M; Bauersachs J; Arad M; Ben Gal T; Lund LH; Felix SB; Arbustini E; Caforio ALP; Farmakis D; Filippatos GS; Gialafos E; Kanjuh V; Krljanac G; Limongelli G; Linhart A; Lyon AR; Maksimović R; Miličić D; Milinković I; Noutsias M; Oto A; Oto Ö; Pavlović SU; Piepoli MF; Ristić AD; Rosano GMC; Seggewiss H; Ašanin M; Seferović JP; Ruschitzka F; Čelutkiene J; Jaarsma T; Mueller C; Moura B; Hill L; Volterrani M; Lopatin Y; Metra M; Backs J; Mullens W; Chioncel O; de Boer RA; Anker S; Rapezzi C; Coats AJS; Tschöpe C
    Eur J Heart Fail; 2019 May; 21(5):553-576. PubMed ID: 30989768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC).
    de Boer RA; Heymans S; Backs J; Carrier L; Coats AJS; Dimmeler S; Eschenhagen T; Filippatos G; Gepstein L; Hulot JS; Knöll R; Kupatt C; Linke WA; Seidman CE; Tocchetti CG; van der Velden J; Walsh R; Seferovic PM; Thum T
    Eur J Heart Fail; 2022 Mar; 24(3):406-420. PubMed ID: 34969177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of recent advances in the diagnosis of cardiac amyloidosis, treatment of its cardiac complications, and disease-modifying therapies.
    Raval M; Siddiq S; Sharma K; Sanghvi L; Jain A; Patel S; Trivedi J; Uttam Chandani K; Patel D; Desai R
    F1000Res; 2023; 12():192. PubMed ID: 36911240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From Hypertrophy to Heart Failure: What Is New in Genetic Cardiomyopathies.
    Reza N; Musunuru K; Owens AT
    Curr Heart Fail Rep; 2019 Oct; 16(5):157-167. PubMed ID: 31243690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing concepts in heart muscle disease: the evolving understanding of hypertrophic cardiomyopathy.
    Moody WE; Elliott PM
    Heart; 2022 May; 108(10):768-773. PubMed ID: 35459726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transthyretin Cardiac Amyloidosis: An Evolution in Diagnosis and Management of an "Old" Disease.
    Smiley DA; Rodriguez CM; Maurer MS
    Cardiol Clin; 2022 Nov; 40(4):541-558. PubMed ID: 36210137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic causes of heart failure with preserved ejection fraction: emerging pharmacological treatments.
    Olivotto I; Udelson JE; Pieroni M; Rapezzi C
    Eur Heart J; 2023 Feb; 44(8):656-667. PubMed ID: 36582184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of infiltrative cardiomyopathies resulting in heart failure with preserved ejection fraction.
    Madan N; Kalra D
    Rev Cardiovasc Med; 2020 Jun; 21(2):181-190. PubMed ID: 32706207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Therapies and Future Horizons in Cardiac Amyloidosis Treatment.
    Vogel J; Carpinteiro A; Luedike P; Buehning F; Wernhart S; Rassaf T; Michel L
    Curr Heart Fail Rep; 2024 Aug; 21(4):305-321. PubMed ID: 38809394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloidosis in Heart Failure.
    Ihne S; Morbach C; Obici L; Palladini G; Störk S
    Curr Heart Fail Rep; 2019 Dec; 16(6):285-303. PubMed ID: 31782077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).
    Ho CY; Day SM; Ashley EA; Michels M; Pereira AC; Jacoby D; Cirino AL; Fox JC; Lakdawala NK; Ware JS; Caleshu CA; Helms AS; Colan SD; Girolami F; Cecchi F; Seidman CE; Sajeev G; Signorovitch J; Green EM; Olivotto I
    Circulation; 2018 Oct; 138(14):1387-1398. PubMed ID: 30297972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac resynchronization therapy in cardiomyopathies.
    Masarone D; Limongelli G; Ammendola E; Del Giorno G; Colimodio F; D'Andrea A; Pacileo G; Santangelo L; Lambiase PD
    J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):92-9. PubMed ID: 23811838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
    Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards etiological treatments in cardiomyopathies.
    Lairez O; Fournier P; Itier R; Bachelet B; Huart A; Cariou E
    Presse Med; 2024 Mar; 53(1):104223. PubMed ID: 38309622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic Cardiomyopathy versus Storage Diseases with Myocardial Involvement.
    Burban A; Pucyło S; Sikora A; Opolski G; Grabowski M; Kołodzińska A
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart failure as the first manifestation of severe non-cardiac disease.
    Matuszna A; Meryn J; Bachorski W
    Pol Merkur Lekarski; 2019 Aug; 47(278):67-69. PubMed ID: 31473755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation across the spectrum of hypertrophic cardiac phenotypes.
    Lillo R; Graziani F; Franceschi F; Iannaccone G; Massetti M; Olivotto I; Crea F; Liuzzo G
    Heart Fail Rev; 2023 Sep; 28(5):1065-1075. PubMed ID: 37115472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left and right ventricular strain using fast strain-encoded cardiovascular magnetic resonance for the diagnostic classification of patients with chronic non-ischemic heart failure due to dilated, hypertrophic cardiomyopathy or cardiac amyloidosis.
    Steen H; Giusca S; Montenbruck M; Patel AR; Pieske B; Florian A; Erley J; Kelle S; Korosoglou G
    J Cardiovasc Magn Reson; 2021 Apr; 23(1):45. PubMed ID: 33823860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyopathies and specific heart muscle diseases. Definitions, terminology, classifications and new and old approaches.
    Goodwin JF
    Postgrad Med J; 1992; 68 Suppl 1():S3-6. PubMed ID: 1409213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.